You are here: All Products  > BioRay Approved to Launch Anruixi, a CD20 mAb, for B-Cell Lymphoma in China

BioRay Approved to Launch Anruixi, a CD20 mAb, for B-Cell Lymphoma in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products